Company intelligence / Profile preview
PreveCeutical Medical Inc.
Vancouver, British Columbia, Canadapreveceutical.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
PreveCeutical is developing multiple programs including cannabinoid sol-gel delivery systems, non-addictive analgesic peptides, BSV peptide program for cancer, and dual gene therapy for diabetes and obesity. The company is currently in pre-clinical evaluation stages.
- Therapeutic areas
- OncologyEndocrinologyNeurology
- Modalities
- PeptidesSol-Gel Delivery SystemCannabinoidsGene Therapy
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
University of QueenslandUniQuest
Beyond the preview
Go deeper on PreveCeutical Medical Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PreveCeutical Medical Inc..